Objective:
To highlight the features and benefits of Bausch + Lomb's TENEO excimer laser for LASIK surgery.
Key Findings:
- TENEO operates faster than competitors, correcting at 1.2 seconds per diopter.
- No nomogram requirement simplifies surgical planning and reduces transcription errors.
- 97.8% of eyes achieved uncorrected distance visual acuity of 20/25 or better at 9 months.
- Improved patient outcomes include better contrast sensitivity and reduced night-driving symptoms.
Interpretation:
The TENEO excimer laser represents a significant advancement in LASIK technology, promising enhanced efficiency, safety, and patient satisfaction.
Limitations:
- Currently approved only for myopia and myopic astigmatism.
- Future approvals for a wider range of corrections are anticipated but not yet available.
Conclusion:
The TENEO excimer laser is poised to improve LASIK surgery outcomes significantly, with potential for broader applications in the future.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







